MGLL Antibody
- Known as:
- MGLL Antibody
- Catalog number:
- XW-7936
- Product Quantity:
- 0.05 mg
- Category:
- -
- Supplier:
- Prosci
- Gene target:
- MGLL Antibody
Related genes to: MGLL Antibody
- Gene:
- MGLL NIH gene
- Name:
- monoglyceride lipase
- Previous symbol:
- -
- Synonyms:
- HU-K5, MGL
- Chromosome:
- 3q21.3
- Locus Type:
- gene with protein product
- Date approved:
- 2001-12-13
- Date modifiied:
- 2016-10-05
Related products to: MGLL Antibody
Related articles to: MGLL Antibody
- Endometriosis is a common gynecological disease in which lipid metabolic dysregulation has been increasingly implicated. However, the specific metabolic changes in ectopic lesions and stromal cells remain poorly understood. It is also unclear whether these changes contribute to lipid droplet accumulation or how this process is controlled at the transcriptional level. Here, we report that ectopic stromal cells exhibit broad lipid remodeling, showing changes in phosphatidylcholines, lysophosphatidylcholines, sphingomyelins, and acylcarnitines. Both ectopic lesions and ectopic stromal cells showed increased triacylglycerol and total cholesterol levels, lipid droplet accumulation, and reduced E2F1 expression. Integrated epigenomic and transcriptomic analyses of patient-derived ectopic stromal cells, together with mechanistic validation, revealed that E2F1 transcriptionally activates MGLL, which encodes monoacylglycerol lipase, a lipolytic enzyme involved in lipid mobilization. Both in vitro and in vivo experiments showed that downregulation of E2F1 increased lipid droplet accumulation, whereas restoring MGLL expression partially reversed this effect. Consistently, targeted lipidomic analysis of ectopic stromal cells following MGLL knockdown showed increased levels of several diacylglycerol species and alterations in sphingomyelin profiles. In summary, our findings suggest that E2F1 downregulation reduces MGLL expression and impairs lipid mobilization, which may contribute to lipid droplet accumulation and endometriotic lesion growth. - Source: PubMed
Publication date: 2026/09/28
Wang XiaorongZhu JingwenLi JieHuang YanXue Qing - Thyroid hormones are central regulators of metabolic homeostasis and developmental programming. The active hormone triiodothyronine (T3) modulates transcription through nuclear receptors that recruit epigenetic cofactors to remodel chromatin and regulate metabolic gene networks. Although thyroid hormone signaling is known to influence lipid metabolism, whether it coordinates lipid droplet turnover with autophagy-related pathways during early embryonic development remains largely unknown. Here, transcriptomic profiling revealed distinct metabolic signatures between and embryos, with marked differences in fatty acid metabolism. Supplementation with 50 nM T3 enhanced blastocyst formation, particularly when applied from the 4-cell to blastocyst stages, coinciding with elevated thyroid hormone receptor expression. T3 induced robust lipid droplet remodeling, characterized by reduced droplet size, together with increased lipid-mitochondria colocalization and activation of lysosomal and mitochondrial pathways, consistent with enhanced lipid catabolism and organelle coupling. Mechanistically, inhibition of the histone acetyltransferase KAT2B/PCAF abolished T3-mediated developmental gains, reduced H3K9ac and H3K27ac, and resulted in nonselective autophagic stress rather than lipophagy. By contrast, T3 required KAT2B to stimulate cytosolic lipolysis, channel fatty acids into mitochondria, and enhance mitochondrial membrane potential. T3 also upregulated prostaglandin biosynthesis genes and improved outgrowth performance. These findings identify a thyroid hormone-KAT2B epigenetic axis that coordinates lipid droplet remodeling through lipolytic and lipophagic pathways, linking endocrine signaling to organelle crosstalk and mitochondrial activation during early embryogenesis. ART: assisted reproductive technology; ATG5: autophagy related 5; BSA: bovine serum albumin; BSCL2/SEIPIN: BSCL2 lipid droplet biogenesis associated, seipin; CARM1: coactivator associated arginine methyltransferase 1; COCs: cumulus-oocyte complexes; CPT1A: carnitine palmitoyltransferase 1A; CPT2: carnitine palmitoyltransferase 2; CREBBP/CBP: CREB binding protein; DEGs: differentially expressed genes; DGAT1: diacylglycerol O-acyltransferase 1; EP300: E1A binding protein p300; ER: endoplasmic reticulum; H3K9ac: histone H3 acetyl-Lys9; H3K27ac: histone H3 acetyl-Lys27; HCS: high-content screening; HDACs: histone deacetylases; IVC: in vitro culture; IVF: in vitro-fertilized embryos; IVM: in vitro maturation; IVO: in vivo embryos; KAT2A/GCN5: K(lysine) acetyltransferase 2A; KAT2B/PCAF: K(lysine) acetyltransferase 2B; KAT2Bi (Ki): KAT2B inhibition; KD: knockdown; LC3: microtubule associated protein 1 light chain 3; LDs: lipid droplets; LIPE/HSL: lipase E, hormone sensitive type; MGLL: monoglyceride lipase; MMP: mitochondrial membrane potential; mtDNA: mitochondrial DNA; MT-ND1: mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1; PA: parthenogenetically activated; PG: prostaglandin; PLA2G4A: phospholipase A2 group IVA; PLIN2: perilipin 2; PLIN3: perilipin 3; PLIN5: perilipin 5; PNPLA2/ATGL: patatin like phospholipase domain containing 2; PPARD/PPARδ: peroxisome proliferator activated receptor delta; PPARs: peroxisome proliferator activated receptors; PRMT1: protein arginine methyltransferase 1; PTGS1: prostaglandin-endoperoxide synthase 1; PTGS2: prostaglandin-endoperoxide synthase 2; PVA: polyvinyl alcohol; RT: room temperature; RT-qPCR: reverse transcription-quantitative polymerase chain reaction; RXR: retinoid X receptor; SIRT1: sirtuin 1; SLC25A20/CACT: solute carrier family 25 member 20; SLC27A4/FATP4: solute carrier family 27 member 4; SUV39H1: SUV39H1 histone lysine methyltransferase; T3: triiodothyronine; T4: thyroxine; TAGs: triacylglycerols; TEM: transmission electron microscopy; THR: thyroid hormone receptor; THRA: thyroid hormone receptor alpha; THRA-i: thyroid hormone receptor antagonist; THRB: thyroid hormone receptor beta; THs: thyroid hormones; ZGA: zygotic genome activation. - Source: PubMed
Publication date: 2026/09/24
Lee Song-HeeZhan Cheng-LinCui Xiang-Shun - Meat quality is an important economic trait in beef cattle and is influenced by breed-related metabolic characteristics. Yanbian cattle (YB) are valued for desirable meat quality, whereas Yanhuang cattle (YH), developed using Limousin cattle as the paternal line and Yanbian cattle as the maternal line, exhibit improved growth performance and carcass yield. However, the molecular basis underlying metabolic variation between these two genetically related cattle populations remains unclear. In this study, longissimus thoracis muscle samples from six animals per breed were analyzed using LC-MS/MS-based metabolomics and GC×GC-TOF/MS-based volatile compound profiling, and a subset of three samples per breed from the same cohort was selected for transcriptomic sequencing. A total of 1697 metabolites were detected. Based on the screening criteria of VIP > 1 and < 0.05, 202 candidate metabolites were identified, among which 11 remained statistically significant after false discovery rate (FDR) correction. Volatile compound profiling detected 1333 and 1516 compounds in YB and YH, respectively, of which 809 were shared. Based on the same screening criteria, 39 candidate volatile compounds were identified, although none remained significant after FDR correction. Transcriptomic analysis identified 360 differentially expressed genes using |logFC| > 1 and adjusted < 0.05, with enrichment mainly observed in pathways associated with carbohydrate metabolism, lipid turnover, and energy utilization. Integrative analyses indicated that amino acid-related metabolites, including phenylpyruvate, 2-aminobenzoic acid, and asparagine, were more closely associated with candidate volatile compounds than metabolites involved in central carbon metabolism. Several genes involved in lipid metabolism, energy metabolism, and muscle structure, including , , , , , , , and , were associated with distinct metabolic modules. These findings provide an exploratory view of breed-related metabolic variation and identify candidate molecular features for future validation. - Source: PubMed
Publication date: 2026/08/10
Lyu YangZhu ZhiweiZhao BaoxinRen ZezhuZhou MengYu JingDing HeLiu HongyuFang YiZhao JingLyu Wenfa - Lamivudine and abacavir are key components of first-line paediatric antiretroviral therapy (ART). Rifampicin is part of drug-sensitive TB treatment in children. Rifampicin induces UDP-glucuronosyltransferases and renal transporters and inhibits gastrointestinal transporters involved in the pharmacokinetics of abacavir and lamivudine, but pharmacokinetic data on this potential interaction in infants are scarce. - Source: PubMed
Beca Laize Sílvia Dos Anjos BotasMumbiro VivianBwakura MutsaMujuru Hilda AMudzingwa ShepherdTagarro AlfredoDomínguez-Rodríguez SaraMusiime VictorNalwanga DamalieBuck W ChrisSacarlal JahitChabala ChishalaChansa Bwendo NdunaRojo PabloBurger David MMoraleda CintaJacobs Tom G - Osteoarthritis (OA) is a chronic, progressive joint disorder with higher prevalence and pain severity in women than men. The endocannabinoid system (ECS) modulates pain and shows sexual dimorphism, yet sex-specific alterations in central ECS signalling in OA pain remain under-investigated. - Source: PubMed
Publication date: 2026/07/19
Ferdousi Mehnaz IInfantino RosmaraRedmond Maria CKrishnan Santhosh DAdjei Canny KMcDermott BarryLiddy AlisonQuinlan LeoO'Halloran MartinFinn David P